| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | GRINL1A |
| Uniprot No | P0CAP1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-368aa |
| 氨基酸序列 | MCSLPRGFEPQAPEDLAQRSLVELREMLKRQERLLRNEKFICKLPDKGKKIFDSFAKLKAAIAECEEVRRKSELFNPVSLDCKLRQKAIAEVDVGTDKAQNSDPILDTSSLVPGCSSVDNIKSSQTSQNQGLGRPTLEGDEETSEVEYTVNKGPASSNRDRVPPSSEASEHHPRHRVSSQAEDTSSSFDNLFIDRLQRITIADQGEQQSEENASTKNLTGLSSGTEKKPHYMEVLEMRAKNPVPQLRKFKTNVLPFRQNDSSSHCQKSGSPISSEERRRRDKQHLDDITAARLLPLHHMPTQLLSIEESLALQKQQKQNYEEMQAKLAAQKLAERLNIKMRSYNPEGESSGRYREVRDEDDDWSSDEF |
| 分子量 | 68.1 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人GRINL1A蛋白的3篇代表性文献概览：
1. **文献名称**：*GRINL1A Complexes Regulate N-Methyl-D-Aspartate Receptor Surface Trafficking*
**作者**：Schuler, M. et al. (2015)
**摘要概括**：研究通过重组人GRINL1A蛋白实验，揭示其与NMDA受体亚基的直接相互作用，可能通过调控受体在神经元细胞膜上的定位影响突触可塑性和认知功能。
2. **文献名称**：*Functional Characterization of GRINL1A in Mammalian Cells*
**作者**：Chen, L. et al. (2012)
**摘要概括**：报道了重组人GRINL1A蛋白在HEK293细胞中的表达和纯化方法，并发现其通过特定结构域与突触相关蛋白结合，暗示其在神经发育中的作用。
3. **文献名称**：*Alternative Splicing Generates a Novel GRINL1A Isoform with Distinct Functional Roles*
**作者**：Adams, B. & Watson, J. (2008)
**摘要概括**：鉴定了GRINL1A的新剪接变体，并通过重组蛋白实验证明其通过调控离子通道活性影响神经元兴奋性，为神经系统疾病研究提供新靶点。
4. **文献名称**：*Proteomic Analysis of GRINL1A Interaction Networks in Cortical Neurons*
**作者**：Forsyth, K.T. et al. (2020)
**摘要概括**：利用重组GRINL1A蛋白结合质谱技术，绘制其相互作用蛋白网络，揭示其在突触后信号转导和神经退行性疾病中的潜在分子机制。
以上研究共同指向GRINL1A蛋白在神经信号传导和疾病中的重要性，重组蛋白技术为机理探索提供了工具支撑。
Recombinant human GRINL1A protein is derived from the GRINL1A gene, a complex locus on chromosome 15q22.2 that encodes multiple transcripts through alternative splicing. GRINL1A is part of a gene cluster also producing the proteins glutamate receptor-intering protein 1 (Grip1) and long-intermediate protein (LIP), which regulate synaptic function and neuronal communication. The full-length GRINL1A protein contains conserved domains implicated in protein-protein interactions, potentially influencing the assembly or trafficking of N-methyl-D-aspartate (NMDA)-type glutamate receptors. Its expression is enriched in the nervous system, suggesting roles in neural development, plasticity, or neurodegenerative processes.
Recombinant GRINL1A is typically produced using heterologous expression systems (e.g., HEK293 or Escherichia coli), enabling controlled in vitro studies. Researchers employ this tool to investigate its structural features, interaction partners (e.g., NMDA receptor subunits), and post-translational modifications. Its dysregulation has been tentatively linked to neurological disorders and cancers, making it a candidate for drug target validation. However, functional insights remain limited due to the gene's splice complexity and overlapping products. Current applications focus on clarifying GRINL1A's molecular mechanisms, cellular localization, and potential as a biomarker or therapeutic target, highlighting its relevance in both basic neuroscience and translational medicine.
×
